Bissonnette R, Goleva E, Berdyshev E, Leung DYM, et al. In response to: "Response to Bissonnette et al. Dupilumab treatment restores lesional and non-lesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy. J Am Acad Dermatol 2025 Aug 29:S0190-9622(25)02705.
PMID: 40886838